Signals, Powered By EquityPandit
The US health regulator has provided its approval to Alembic Pharmaceuticals for generic Fluoxetine Hydrochloride tablets that are used in treating depression and panic disorder.
Alembic Pharma has said in a BSE filing that “The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application for Fluoxetine Hydrochloride tablets, 10 mg and 20 mg.”
It further added that according to IMS these tablets have an estimated market size of USD 120 million for 12 months ending December 2015.
